These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27370648)

  • 1. Quality of care provided to prostate cancer (PC) patients for prevention and treatment of osteoporosis induced by androgen deprivation therapy (ADT).
    Chahin R; Gulamhusein H; Breunis H; Alibhai SM
    Support Care Cancer; 2016 Nov; 24(11):4713-20. PubMed ID: 27370648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone health management in prostate cancer patients receiving androgen deprivation therapy.
    Dhanapal V; Reeves DJ
    J Oncol Pharm Pract; 2012 Mar; 18(1):84-90. PubMed ID: 21807761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone health management in men undergoing ADT: examining enablers and barriers to care.
    Damji AN; Bies K; Alibhai SM; Jones JM
    Osteoporos Int; 2015 Mar; 26(3):951-9. PubMed ID: 25526712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen deprivation in veterans with prostate cancer: implications for skeletal health.
    Wilcox A; Carnes ML; Moon TD; Tobias R; Baade H; Stamos E; Elliott ME
    Ann Pharmacother; 2006 Dec; 40(12):2107-14. PubMed ID: 17132807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer.
    Panju AH; Breunis H; Cheung AM; Leach M; Fleshner N; Warde P; Duff-Canning S; Krahn M; Naglie G; Tannock I; Tomlinson G; Alibhai SM
    BJU Int; 2009 Mar; 103(6):753-7. PubMed ID: 19007370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone health care for patients with prostate cancer receiving androgen deprivation therapy.
    Tsang DS; Alibhai SM
    Hosp Pract (1995); 2014 Apr; 42(2):89-102. PubMed ID: 24769788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis due to androgen deprivation therapy in men with prostate cancer.
    Daniell HW
    Urology; 2001 Aug; 58(2 Suppl 1):101-7. PubMed ID: 11502461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and management of osteoporosis in men receiving androgen deprivation therapy: a survey of urologists and radiation oncologists.
    Alibhai SM; Rahman S; Warde PR; Jewett MA; Jaffer T; Cheung AM
    Urology; 2006 Jul; 68(1):126-31. PubMed ID: 16844454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis during androgen deprivation therapy for prostate cancer.
    Smith MR
    Urology; 2002 Sep; 60(3 Suppl 1):79-85; discussion 86. PubMed ID: 12231056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving bone health in prostate cancer patients starting androgen deprivation therapy: does Fracture Risk Assessment Tool (FRAX®) enhance stratification and targeted management?
    Sharqawi A; Hewitt K; Alexander C; El-Sakka AI; Lee L
    Arch Osteoporos; 2022 Nov; 17(1):143. PubMed ID: 36376762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoting calcium and vitamin D intake to reduce the risk of osteoporosis in men on androgen deprivation therapy for recurrent prostate cancer.
    Davison BJ; Wiens K; Cushing M
    Support Care Cancer; 2012 Oct; 20(10):2287-94. PubMed ID: 22138848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The implications of baseline bone-health assessment at initiation of androgen-deprivation therapy for prostate cancer.
    Kirk PS; Borza T; Shahinian VB; Caram MEV; Makarov DV; Shelton JB; Leppert JT; Blake RM; Davis JA; Hollenbeck BK; Sales A; Skolarus TA
    BJU Int; 2018 Apr; 121(4):558-564. PubMed ID: 29124881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy.
    Grossmann M; Hamilton EJ; Gilfillan C; Bolton D; Joon DL; Zajac JD
    Med J Aust; 2011 Mar; 194(6):301-6. PubMed ID: 21426285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis and fractures after androgen deprivation initiation for prostate cancer.
    Malcolm JB; Derweesh IH; Kincade MC; DiBlasio CJ; Lamar KD; Wake RW; Patterson AL
    Can J Urol; 2007 Jun; 14(3):3551-9. PubMed ID: 17594745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of osteoporosis in men on androgen deprivation therapy.
    Adler RA
    Maturitas; 2011 Feb; 68(2):143-7. PubMed ID: 21129866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis and prostate cancer: a cross-sectional study of Danish men with prostate cancer before androgen deprivation therapy.
    Poulsen MH; Frost M; Abrahamsen B; Brixen K; Walter S
    Scand J Urol; 2014 Aug; 48(4):350-5. PubMed ID: 24548220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintaining bone health in patients with prostate cancer.
    Holmes-Walker DJ; Woo H; Gurney H; Do VT; Chipps DR
    Med J Aust; 2006 Feb; 184(4):176-9. PubMed ID: 16489902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of bone loss in men with prostate cancer.
    Higano CS
    J Urol; 2003 Dec; 170(6 Pt 2):S59-63; discussion S64. PubMed ID: 14610412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrition education for osteoporosis prevention in men with prostate cancer initiating androgen deprivation therapy.
    Millar H; Davison J
    Clin J Oncol Nurs; 2012 Oct; 16(5):497-503. PubMed ID: 23022933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications.
    Shao YH; Moore DF; Shih W; Lin Y; Jang TL; Lu-Yao GL
    BJU Int; 2013 May; 111(5):745-52. PubMed ID: 23331464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.